Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19

被引：57
|
作者：
Focosi, Daniele [1 ]
Novazzi, Federica [2 ]
Genoni, Angelo [3 ]
Dentali, Francesco [2 ,3 ]
Gasperina, Daniela Dalla [2 ,3 ]
Baj, Andreina [2 ,3 ]
Maggi, Fabrizio [2 ,3 ]
机构：
[1] Pisa Univ Hosp, Pisa, Italy
[2] Azienda Sociosanitaria Terr, Varese, Italy
[3] Univ Insubria, Via Dunant 5, I-21100 Varese, Italy
来源：
EMERGING INFECTIOUS DISEASES | 2021年 / 27卷 / 10期
关键词：
D O I：
10.3201/eid2710.211538
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient who had coronavirus disease and was treated with these drugs.
引用
收藏
页码：2728 / 2731
页数：4
相关论文
共 50 条
  • [1] Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance
    Guigon, Aurelie
    Faure, Emmanuel
    Lemaire, Chloe
    Chopin, Marie-Charlotte
    Tinez, Claire
    Assaf, Ady
    Lazrek, Mouna
    Hober, Didier
    Bocket, Laurence
    Engelmann, Ilka
    Alidjinou, Enagnon Kazali
    JOURNAL OF INFECTION, 2022, 84 (02) : 273 - 276
  • [2] Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients
    George, Santosh
    Pal, Anasuya Chattopadhyay
    Gagnon, Jacqueline
    Timalsina, Sushma
    Singh, Pallavi
    Vydyam, Pratap
    Munshi, Muhammad
    Chiu, Joy E.
    Renard, Isaline
    Harden, Christina A.
    Ott, Isabel M.
    Watkins, Anne E.
    Vogels, Chantal B. F.
    Lu, Peiwen
    Tokuyama, Maria
    Venkataraman, Arvind
    Casanovas-Massana, Arnau
    Wyllie, Anne L.
    Rao, Veena
    Campbell, Melissa
    Farhadian, Shelli F.
    Grubaugh, Nathan D.
    Dela Cruz, Charles S.
    Ko, Albert, I
    Perez, Amalia Z. Berna
    Akaho, Elikplim H.
    Moledina, Dennis G.
    Testani, Jeffrey
    John, Audrey R.
    Ledizet, Michel
    Ben Mamoun, Choukri
    KIDNEY360, 2021, 2 (06): : 924 - 936
  • [3] COVID-19: Avoiding culture shock with the SARS-CoV-2 spike protein
    Hale, Benjamin G.
    ELIFE, 2021, 10
  • [4] From COVID-19 to the Central Dogma: Investigating the SARS-CoV-2 Spike Protein
    McGuire, George P.
    Luna, Camila, V
    Staehling, Erica M.
    Stroupe, M. Elizabeth
    AMERICAN BIOLOGY TEACHER, 2022, 84 (07): : 410 - 414
  • [5] Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
    Zhang, Bao-zhong
    Hu, Ye-fan
    Chen, Lin-lei
    Yau, Thomas
    Tong, Yi-gang
    Hu, Jing-chu
    Cai, Jian-piao
    Chan, Kwok-Hung
    Dou, Ying
    Deng, Jian
    Wang, Xiao-lei
    Hung, Ivan Fan-Ngai
    To, Kelvin Kai-Wang
    Yuen, Kwok Yung
    Huang, Jian-Dong
    CELL RESEARCH, 2020, 30 (08) : 702 - 704
  • [6] Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia, Zaixing
    Gong, Wenping
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (18)
  • [7] Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
    Bao-zhong Zhang
    Ye-fan Hu
    Lin-lei Chen
    Thomas Yau
    Yi-gang Tong
    Jing-chu Hu
    Jian-piao Cai
    Kwok-Hung Chan
    Ying Dou
    Jian Deng
    Xiao-lei Wang
    Ivan Fan-Ngai Hung
    Kelvin Kai-Wang To
    Kwok Yung Yuen
    Jian-Dong Huang
    Cell Research, 2020, 30 : 702 - 704
  • [8] Comment on SARS-CoV-2 genome and spike protein, COVID-19, and efficacy of vaccines
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    CIRUGIA Y CIRUJANOS, 2025, 93 (01):
  • [9] COVID-19: emergence and mutational diversification of SARS-CoV-2
    Brussow, Harald
    MICROBIAL BIOTECHNOLOGY, 2021, 14 (03): : 756 - 768
  • [10] Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
    Shailendra K. Saxena
    Swatantra Kumar
    Preeti Baxi
    Nishant Srivastava
    Bipin Puri
    R. K. Ratho
    VirusDisease, 2020, 31 (4) : 399 - 407
12345